Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

29
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
29
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

30
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
30
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

40
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
40
Microbial Growth Measurement: Indirect Methods01:27

Microbial Growth Measurement: Indirect Methods

632
Estimating microbial growth is essential for understanding population dynamics and environmental adaptations. Indirect methods provide valuable insights by measuring parameters such as turbidity, metabolic activity, and biomass, enabling efficient and reproducible assessments.During exponential growth, microbial cells scatter light proportionally to their biomass, a principle used in turbidity measurements. About one million cells per milliliter produce detectable scattering, which a...
632
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.7K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.7K
Pulmonary Function Tests01:25

Pulmonary Function Tests

471
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
471

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Crash injury assessment for wheelchair users using parametric human models and scalable manual wheelchair finite element models.

Traffic injury prevention·2026
Same author

Crashworthiness of WC19 Wheelchairs in Horizontal Dynamic Aircraft Seating Tests.

SAE international journal of transportation safety·2026
Same author

Evaluation of THOR-50M-RS under reclined seating conditions.

Traffic injury prevention·2025
Same author

Development of A Generic Nearside Impact Test Fixture for Evaluating In-Vehicle Crashworthiness of Wheelchairs.

Stapp car crash journal·2025
Same author

Exploring advanced restraint technologies for improving safety equity for rear-seat occupants using diverse human body models.

Traffic injury prevention·2025
Same author

Development and validation of a set of wheelchair finite element models in frontal, side, and rear impact conditions.

Traffic injury prevention·2024

Related Experiment Video

Updated: Oct 23, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K

Dynamic metrics to differentiate booster performance.

Kathleen D Klinich1, Miriam A Manary, Kyle J Boyle

  • 1University of Michigan Transportation Research Institute, Ann Arbor, Michigan.

Traffic Injury Prevention
|August 25, 2021
PubMed
Summary
This summary is machine-generated.

New metrics can identify less effective child seat belt positioning boosters by simulating real-world crash dynamics. This research evaluated booster performance to improve child safety in vehicles.

Keywords:
Boostersdynamic performancemetrics

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.9K
Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.1K

Related Experiment Videos

Last Updated: Oct 23, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.9K
Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.1K

Area of Science:

  • Automotive safety engineering
  • Biomechanics
  • Child passenger safety

Background:

  • Current Federal Motor Vehicle Safety Standard (FMVSS) No. 213 booster performance requirements are achievable even with ineffective booster systems.
  • Field data confirm that belt-positioning boosters significantly reduce injury risk for children.
  • A need exists for more discerning booster performance metrics.

Purpose of the Study:

  • To explore and evaluate candidate booster performance metrics.
  • To identify metrics capable of distinguishing less effective booster systems.
  • To assess potential testing measures against a no-booster condition.

Main Methods:

  • Dynamic testing was conducted using a surrogate seat belt retractor on a preliminary FMVSS No. 213 seat assembly.
  • Eleven booster products and a no-booster condition were evaluated.
  • Tests utilized Hybrid III 10-year-old (6 tests) and Hybrid III 6-year-old (33 tests) anthropomorphic test devices (ATDs).

Main Results:

  • Candidate metrics associated with optimal ATD kinematics (preventing submarining and rollout) were identified.
  • Key metrics included: difference between knee and head excursion, maximum torso angle, lumbar spine Moment Z, and lumbar spine Force Y.

Conclusions:

  • Proposed metrics, when applied under realistic dynamic testing conditions, can better differentiate booster performance.
  • These metrics provide a clearer distinction of less effective boosters compared to the no-booster condition.
  • The findings support the development of improved booster testing standards for enhanced child safety.